- Report
- February 2025
- 85 Pages
India
From €3111EUR$3,500USD£2,715GBP
- Report
- December 2024
- 85 Pages
India
From €3111EUR$3,500USD£2,715GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2666EUR$3,000USD£2,327GBP
€3333EUR$3,750USD£2,908GBP
- Report
- July 2024
- 150 Pages
Global
From €2666EUR$3,000USD£2,327GBP
€3333EUR$3,750USD£2,908GBP
- Report
- July 2024
- 150 Pages
Global
From €2666EUR$3,000USD£2,327GBP
€3333EUR$3,750USD£2,908GBP
- Report
- July 2024
- 100 Pages
Global
From €2666EUR$3,000USD£2,327GBP
€3333EUR$3,750USD£2,908GBP
- Report
- June 2024
- 200 Pages
Global
From €5653EUR$6,360USD£4,933GBP
€7066EUR$7,950USD£6,166GBP
- Report
- February 2024
- 30 Pages
Global
From €2311EUR$2,600USD£2,017GBP
€2888EUR$3,250USD£2,521GBP
- Report
- January 2024
- 189 Pages
Global
From €5333EUR$6,000USD£4,654GBP
€6666EUR$7,500USD£5,817GBP
- Report
- November 2023
- 30 Pages
Global
From €1955EUR$2,200USD£1,706GBP
€2444EUR$2,750USD£2,133GBP
- Report
- November 2023
- 30 Pages
Global
From €1955EUR$2,200USD£1,706GBP
€2444EUR$2,750USD£2,133GBP
- Report
- November 2023
- 30 Pages
Global
From €1955EUR$2,200USD£1,706GBP
€2444EUR$2,750USD£2,133GBP
- Report
- February 2023
- 107 Pages
Global
From €5333EUR$6,000USD£4,654GBP
€6666EUR$7,500USD£5,817GBP
- Report
- February 2023
- 50 Pages
Global
From €2808EUR$3,160USD£2,451GBP
€3511EUR$3,950USD£3,064GBP
- Report
- October 2024
- 200 Pages
Global
From €3333EUR$3,750USD£2,908GBP
- Report
- May 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,219GBP
- Report
- March 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,219GBP
- Report
- March 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,219GBP
- Report
- August 2023
- 145 Pages
Global
From €2800EUR$3,150USD£2,443GBP
- Report
- December 2024
- 30 Pages
Global
From €2311EUR$2,600USD£2,017GBP
€2888EUR$3,250USD£2,521GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more